“rheumatoid-arthritis” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca 12/18/18 San Diego
With $45M, HotSpot Takes Drug Research to New Biological Real Estate 07/17/18 Boston
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning 06/01/18 Indiana
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses 04/23/18 Indiana
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
As AMD Race Tightens, Regeneron’s Second Eye Drug Combo Falls Short 11/27/17 New York
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
Rigel Touts Late-Stage Data for Platelet Drug 08/30/16 San Francisco
GSK, Verily Team Up For Electro-Implants That Monitor, Treat Patients 08/02/16 San Francisco
With New Data, Alder Keeps Pace in Migraine Drug Race 03/28/16 Seattle
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding 09/08/15 San Francisco
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Page 1 of 5 next page »